T1	Treatment 13 22	ibopamine
T2	Treatment 138 147	Ibopamine
T3	Treatment 597 606	ibopamine
T4	Treatment 614 621	placebo
T5	Treatment 694 743	Ibopamine was employed at a dose of 100 mg t.i.d.
T6	Treatment 744 1030	in 97 patients (aged 31-83 years) belonging to NYHA class II and III with congestive heart failure of different aetiology, but without any complex ventricular arrhythmias in basal conditions (couplets with R'-R" less than or equal to 400 msec, ventricular tachycardia, R on T phenomena)
T7	Treatment 1103 1197	Holter recordings in basal conditions and following 7 days of ibopamine and placebo treatment.
